Eagles Face Criticism Over Management of Jalen Hurts’ Blood-Clotting Condition
The Philadelphia Eagles are facing criticism for their management of star quarterback Jalen Hurts' season-ending blood-clotting condition.
Colorado Springs Pueblo, CO, October 20, 2026 —
The Philadelphia Eagles are facing criticism over their management of star quarterback Jalen Hurts’ blood-clotting condition, which is described as season-ending. The available information does not identify who raised the criticism or detail what aspects of the team’s handling are being questioned.
No information was provided about when the condition was diagnosed, what medical decisions were made, or how those decisions affected Hurts’ availability. The specific nature of the blood-clotting condition was also not provided. The team’s response to the criticism, if any, was not included in the available summary.
Those missing details limit what can be established about the dispute. The information provided does not describe the medical care Hurts received, identify any disagreement among medical professionals, or state whether the criticism concerns communication, treatment, or another matter. It also does not provide a timeline for the condition or for the team’s handling of it.
What is stated is that the Eagles are facing criticism and that Hurts’ blood-clotting condition is season-ending. Further specifics about the criticism and the team’s decisions were not available, so no additional conclusions about the management of the condition can be drawn from the information provided.
Story summarized from the original created by Dominick Mastrangelo and The Hill on www.fox21news.com, see more information here.
Media gallery
